APO-Zoledronic Acid (Zoledronic acid)

zoledronic acid 4 mg/5 mL injection, 5 mL vial · INJECTION · PBS code 9653C

STREAMLINED

What it costs

AU$45.72 PBS-determined price per 1 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 2015-12-01.
• Repeats: 11.
• PBS program: HB.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Multiple myeloma

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Bone metastases

The condition must be due to breast cancer.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Bone metastases

The condition must be due to castration-resistant prostate cancer.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Hypercalcaemia of malignancy

Patient must have a malignancy refractory to anti-neoplastic therapy.

Sponsor: Apotex Pty Ltd ABN 52 096 916 148

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.